EUFEPS Annual Meeting 2016

Please, note the new date and location.

The theme of the EUFEPS 2016 meeting is “Clinical Outcome and Regulatory Approaches for Advanced Drug Delivery Products”

As the pharmaceutical world is moving towards more specialized treatments and safer and more efficient administration of existing therapeutic molecules, advanced drug delivery techniques such as non-biological complex drugs (NBCDs), biologics/biotech products, inhaler systems, combination products and modified release products are gaining importance in this current “post blockbuster drug era”. Rapid developments in biosimilar and nanosimilar products also underline the growing need for harmonization and drawing of clear regulatory paths for these innovative systems and their follow-on products.  Personalized medicine and treatments based on pharmacogenomic-pharmacogenetic approaches can be a beacon in increasing the efficacy and safety of innovative treatment while manufacturing and upscaling issues and new biomaterials and techniques need to be explored to render optimum quality attributes to advanced technology pharmaceuticals.

With this in mind, we have put together a 3-day programme with contributions form EUFEPS Networks on Bioavailability/Biopharmaceutics, Nanomedicine, Systems Pharmacology, QbD-PAT, Regulatory Sciences and Pharmacogenetics/ Pharmacogenomics. The meeting will take place in Antalya, Turkey, where you can enjoy both this scientific programme and visit with collegues and friends in a nice area. EUFEPS is celebrating its 25th anniversary in 2016 and we will be more than happy to welcome you at the Gala Dinner dedicated to this silver anniversary for EUFEPS.

Please check our website at www.eufepsannualmeeting.org which will now be continuoulsy updateed and feel free to contact anyoone in the organisation of it for any further information.  Hoping to see you in Antalya in June 2016.

Involvement: 
Organised by EUFEPS
Location: 
Marmara Hotel Lara, Antalya, Turkey
Date: 
Wednesday, November 2, 2016 to Friday, November 4, 2016